Advanced search
Publication Cover
Blood Pressure Volume 33, 2024 - Issue 1
Submit an article Journal homepage
700
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney

Jean-Michel Halimia Service de Néphrologie-Hypertension, Dialyses, Transplantation rénale, Hôpital Bretonneau, Tours, FranceCorrespondence[email protected]
View further author information
,
Pantelis Sarafidisb School of Medicine, Aristotle University of Thessaloniki, GreeceView further author information
,
Michel Azizic Université Paris Cité Department of Cardiology, Paris, France;d APHP, Service d’Hypertension Artérielle, Hôpital Européen Georges Pompidou, Paris, FranceView further author information
,
Grzegorz Biloe Grzegorz Bilo, Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy;f Department of Medicine and Surgery, University of Milano-Bicocca, Milan, ItalyView further author information
,
Thilo Burkardg Medical Outpatient Department and Hypertension Clinic, University Hospital Basel, Basel, SwitzerlandView further author information
,
Michael Bursztynh Hypertension Clinic, Hadassah-Hebrew University Medical Center, Mount Scopus, Jerusalem;i Faculty of Medicine, School of Medicine, Hadassah-Hebrew University, Jerusalem, IsraelORCID Iconhttps://orcid.org/0000-0001-7239-0501View further author information
ORCID Icon,
Miguel Camafortj Hypertension Unit, Department of Internal Medicine, Hospital Clinic, University of Barcelona, SpainView further author information
,
Neil Chapmank Peart-Rose Clinic, Hammersmith Hospital, Imperial College Healthcare Trust, London, UKORCID Iconhttps://orcid.org/0000-0003-1307-9275View further author information
ORCID Icon,
Santina Cottonel PROMISE Department, Nephrology and Dialisys Unit with Hypertension ESH Excellence Centre, University Hospital P.Giaccone, Palermo, Italy;m University of Palermo Department of Nephrology, Palermo, ItalyView further author information
,
Tine de Backern Department of Cardiovascular Diseases, Internal Medicine, University Hospital Ghent, Ghent, BelgiumView further author information
,
Jaap Deinumo Department of Medicine, Radboud University Medical Center, Nijmegen, the NetherlandsORCID Iconhttps://orcid.org/0000-0003-2465-1986View further author information
ORCID Icon,
Philippe Delmottep Hypertension Unit (European Society of Hypertension Excellence Centre), Department of Cardiology, HELORA University Hospitals, Mons, BelgiumORCID Iconhttps://orcid.org/0000-0002-8789-8225View further author information
ORCID Icon,
Maria Dorobantuq Emergency Clinical Hospital of Bucharest Department of Emergency Medicineap: Department of Cardiology, Bucharest, RomaniaView further author information
,
Michalis Doumasr 2 Prop Department of Internal Medicine, Aristotle University, Thessaloniki, GreeceView further author information
,
Rainer Dusings Hypertoniezentrum Bonn, Schwerpunktpraxis Kardiologie, Angiologie, Prävention, Rehabilitation, Bonn, GermanyView further author information
,
Béatrice Duly-Bouhanickt Service d’HTA et Therapeutique CHU Rangueil, Toulouse University, Toulouse, FranceORCID Iconhttps://orcid.org/0000-0001-5162-8779View further author information
ORCID Icon,
Jean-Pierre Fauvelu Department of Nephrology and Hypertension, Hôpital Ed Herriot, Lyon, FranceView further author information
,
Pierre Feslerv Department of Internal Medicine, Montpellier University Hospital, Montpellier, France;w PhyMedExp, INSERM U1046, CNRS UMR 9214, University of Montpellier, Montpellier, FranceORCID Iconhttps://orcid.org/0000-0002-7831-6545View further author information
ORCID Icon,
Zbigniew Gaciongx Department of Internal Medicine, Hypertension and Vascular Diseases, Medical University of Warsaw, Warsaw, PolandView further author information
,
Eugenia Gkaliagkousiy 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, GreeceORCID Iconhttps://orcid.org/0000-0002-6324-2475View further author information
ORCID Icon,
Daniel Gordinz Department of Nephrology, Helsinki University Hospital and University of Helsinki, Helsinki, FinlandORCID Iconhttps://orcid.org/0000-0003-1494-8292View further author information
ORCID Icon,
Guido Grassiaa Clinica Medica, University Milano Bicocca, Milan, ItalyView further author information
,
Charalampos Grassosab Hypertension Unit, KAT General Hospital of Attica, GreeceView further author information
,
Dominique Guerrotac Service de Néphrologie, CIC-CRB 1404, INSERM EnVi U1096, CHU Rouen, FranceORCID Iconhttps://orcid.org/0000-0002-5953-5785View further author information
ORCID Icon,
Justine Huartad Division of Nephrology, University of Liège Hospital (ULg CHU), University of Liège, and Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA), Cardiovascular Sciences, University of Liège, Liège, BelgiumORCID Iconhttps://orcid.org/0000-0002-5455-8769View further author information
ORCID Icon,
Raffaele Izzoae Department of Advanced Medical Sciences, Federico II University of Naples, ItalyORCID Iconhttps://orcid.org/0000-0002-0308-2836View further author information
ORCID Icon,
Fernando Jaén Águilaaf Vascular Risk Unit, Internal Medicine, Virgen de las Nieves University Hospital, Granada, SpainView further author information
,
Zoltán Járaiag South-Buda Center Hospital, St. Imre University Teaching Hospital, Budapest, HungaryORCID Iconhttps://orcid.org/0000-0003-0650-9361View further author information
ORCID Icon,
Thomas Kahanah Department of Clinical Sciences, Division of Cardiovascular Medicine, Karolinska Institute, Stockholm, Sweden;ai Department of Cardiology, Danderyd University Hospital Corp, Stockholm, SwedenORCID Iconhttps://orcid.org/0000-0001-9909-4956View further author information
ORCID Icon,
Ilkka Kantolaaj Division of Medicine, Turku University Hospital, Turku University, Turku, FinlandORCID Iconhttps://orcid.org/0000-0002-6228-522XView further author information
ORCID Icon,
Eva Kociánováak First Department of Internal Medicine - Cardiology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech RepublicView further author information
,
FlorianP. Limbourgal Dept. of Nephrology and Hypertension, Hypertension Center, Hannover Medical School, Hannover, GermanyORCID Iconhttps://orcid.org/0000-0002-8313-7226View further author information
ORCID Icon,
Marilucy Lopez-Subletam AP-HP, Unité d‘hypertension artérielle, service de médecine interne, Hôpital Avicenne, Bobigny, France;an INSERM UMR 942 MASCOT, Paris 13-Université Paris Nord, FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Bobigny, FranceView further author information
,
Francesca Mallamaciao Grande Ospedale Metropolitano, UOC di Nefrologia abilitata al trapianto renale, CNR Epidemiologia Clinica e Fisiopatologia delle Malattie Renali e dell’Ipertensione Arteriosa, Reggio Calabria, ItalyView further author information
,
Athanasios Manolisap Metropolitan Hospital, Piraeus, GreeceORCID Iconhttps://orcid.org/0000-0002-4273-4489View further author information
ORCID Icon,
Maria Marketouaq Hypertension Outpatient Clinic, Cardiology Department, Heraklion University General Hospital, Heraklion, GreeceView further author information
,
Gert Mayerar Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck Anichstrasse, Innsbruck, AustriaORCID Iconhttps://orcid.org/0000-0003-4605-1789View further author information
ORCID Icon,
Alberto Mazzaas Internal Medicine Unit, Department of Medicine, ESH Excellence Center Unit, ItalyView further author information
,
IainM. MacIntyreat Cardiovascular Risk Clinic, Western General Hospital, Edinburgh, UKORCID Iconhttps://orcid.org/0000-0003-4420-3822View further author information
ORCID Icon,
Jean-Jacques Mouradau Service de Médecine Interne, Hôpital Franco-Britannique, Levallois-Perret, FranceView further author information
,
Maria Lorenza Muiesanav Centro Studi Diagnosi e Cura dell’Ipertensione Arteriosa e del Rischio Cardiovascolare (IARC), University of Brescia and ASST Spedali Civili, ItalyView further author information
,
Edgar Nasraw St George University Medical Center Achrafieh-Beirut, LebanonView further author information
,
Peter Nilssonax Department of Clinical Sciences, Lund University, Skane University Hospital, Malmö, SwedenORCID Iconhttps://orcid.org/0000-0002-5652-8459View further author information
ORCID Icon,
Anna Oliverasay Hypertension and Vascular Risk Unit, Department of Nephrology, Hospital del Mar, IMIM (Hospital del Mar Medical Research Institute), Universitat Pompeu Fabra, Barcelona, SpainORCID Iconhttps://orcid.org/0000-0002-5503-545XView further author information
ORCID Icon,
Olivier Ormezzanoaz UF Hypertension et Athérothrombose, Centre Européen d’Excellence en Hypertension Artérielle, Service de Cardiologie, CHU Michallon, Grenoble, FranceView further author information
,
Vitor Paixão-Diasba Internal Medicine Department, Hospital Centre of Vila Nova de Gaia/Espinho, PortugalORCID Iconhttps://orcid.org/0000-0002-6521-2675View further author information
ORCID Icon,
Ioannis Papadakisbb Hypertension Unit, Dept. of Internal Medicine, University Hospital of Heraklion, Heraklion, GreeceORCID Iconhttps://orcid.org/0000-0002-9121-296XView further author information
ORCID Icon,
Dimitris Papadopoulosbc ESH Excellent Center Hypertension, LAIKO University Hospital, Athens, GreeceView further author information
,
Sabine Perlbd Department of Cardiology, Medical University of Graz, Graz, AustriaView further author information
,
Jorge Polóniabe Department of Medicine CINTESIS RISE, Faculty of Medicine of Porto, PortugalView further author information
,
Roberto Pontremolibf Università degli Studi e IRCCS Ospedale Policlinico San Martino di Genova, ItalyORCID Iconhttps://orcid.org/0000-0003-1238-872XView further author information
ORCID Icon,
Giacomo Puccibg Department of Medicine and Surgery, University of Perugia, Unit of Internal Medicine - Santa Maria Terni Hospital, Terni, ItalyView further author information
,
Nicolás Roberto Roblesbh Badajoz, SpainORCID Iconhttps://orcid.org/0000-0002-3999-3607View further author information
ORCID Icon,
Sébastien Rubinbi Service de Néphrologie-transplantation-dialyse-aphérèses, CHU Bordeaux, FranceORCID Iconhttps://orcid.org/0000-0002-1246-0712View further author information
ORCID Icon,
Luis Miguel Ruilopebj Cardiovascular Risk and Hypertension, Madrid, SpainView further author information
,
Lars Christian Rumpbk Department of Internal Medicine/Nephrology, Heinrich-Heine-University Duesseldorf, Duesseldorf, GermanyView further author information
,
Sahrai Saeedbl Department of Heart Disease, Haukeland University Hospital, Bergen, NorwayView further author information
,
Elias Sanidasbm Department of Cardiology, LAIKO General Hospital, Athens, GreeceView further author information
,
Riccardo Sarzanibn Università Politecnica delle Marche and IRCCS-INRCA Department of Clinical and Molecular Sciences, Ancona, ItalyView further author information
,
Roland Schmiederbo Department of Nephrology, Hypertension University Hospital Erlangen, Friedrich Alexander University Erlangen/Nürnberg, GermanyORCID Iconhttps://orcid.org/0000-0003-2356-5883View further author information
ORCID Icon,
François Silholbp Service de Médecine Vasculaire et Hypertension Artérielle, Centre de compétence régional des maladies artérielles rares, Centre d’excellence Européen en Hypertension Artérielle 264, rue Saint Pierre, CHU Timone, Marseille, FranceView further author information
,
Sekib Sokolovicbq Plava Medical Group, Sarajevo, Bosnia and HerzegovinaView further author information
,
Marit Solbubr University Hospital of North Norway Department of Nephrology cb: Department of Internal Medicine and Cardiology, Tromsø, NorwayORCID Iconhttps://orcid.org/0000-0002-4331-7548View further author information
ORCID Icon,
Miroslav Soucekbs 2nd Department of Internal Medicine, St. Anne’s University Hospital, Brno, Czech Republic;bt Fakulty of Medicine, Masaryk University Brno, Czech RepublicView further author information
,
George Stergioubu School of Medicine, Third Department of Medicine, Sotiria Hospital, Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, Athens, GreeceORCID Iconhttps://orcid.org/0000-0002-6132-0038View further author information
ORCID Icon,
Isabella Sudanobv University Hospital Zurich University Heart Center, Cardiology and University of Zurich, Zurich, SwitzerlandView further author information
,
Ramzi Tabbalatbw Department of Cardiology, Abdali Hospital, Amman, JordanORCID Iconhttps://orcid.org/0000-0003-2628-9618View further author information
ORCID Icon,
Istemihan Tengizbx Division of Cardiology, Izmir Medicana International Hospital, Yenisehir, TurkeyView further author information
,
Helen Triantafyllidiby 2nd Department of Cardiology, Medical School, University of Athens, ATTIKON Hospital, Athens, GreeceView further author information
,
Konstontinos Tsioufisbz 1st Department of Cardiology, National and Kapodistrian University of Athens, Hippocratio Hospital, GreeceView further author information
,
Jan Václavíkca Department of Internal Medicine and Cardiology, University Hospital Ostrava, Czech Republic;cb Faculty of Medicine, University of Ostrava, Czech Republic;ORCID Iconhttps://orcid.org/0000-0001-7847-0967View further author information
ORCID Icon,
Markus van der Gietcc Medinische Klinik für Nephrologie und internistische Intensivtherapie, Charité - Universitätsmedizin Berlin, Berlin, GermanyORCID Iconhttps://orcid.org/0000-0003-3590-5451View further author information
ORCID Icon,
Patricia Van der Niepencd Departement of Nephrology & Hypertension, Universitair Ziekenhuis Brussel Department of Nephrology and Hypertension, VUB, BelgiumORCID Iconhttps://orcid.org/0000-0002-6401-1580View further author information
ORCID Icon,
Franco Veglioce Department of Medical Sciences, University of Turin, ItalyORCID Iconhttps://orcid.org/0000-0002-6654-6247View further author information
ORCID Icon,
RetoM. Venzincf Department of Nephrology, Cantonal Hospital Graubuenden, Chur, SwitzerlandView further author information
,
Margus Viigimaacg Centre of Cardiology, North Estonia Medical Centre, Tallinn University of Technology, Tallinn, EstoniaORCID Iconhttps://orcid.org/0000-0001-5575-5978View further author information
ORCID Icon,
Thomas Weberch Cardiology Department, Klinikum Wels-Grieskirchen, Wels, AustriaORCID Iconhttps://orcid.org/0000-0003-0617-0417View further author information
ORCID Icon,
Jiri Widimskyci IIIrd Internal Department, Centre for Hypertension, General Faculty Hospital, Charles University, Prague, Czech RepublicView further author information
,
Gregoire Wuerznercj Service de néphrologie et d’hypertension, Lausanne University Hospital and University of Lausanne, Lausanne, SwitzerlandORCID Iconhttps://orcid.org/0000-0002-6424-7630View further author information
ORCID Icon,
Parounak Zelveianck Center of Preventive Cardiology, Armenia Parounak Zelveian, Hospital N2 CJSC, Yerevan, ArmeniaORCID Iconhttps://orcid.org/0000-0002-6513-6772View further author information
ORCID Icon,
Pantelis Zebekakiscl Hypertension Unit of the First Department of Medicine, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, GreeceView further author information
,
Stephan Luederscm St. Josefs Hospital, Cloppenburg, GermanyView further author information
,
Alexandre Persucn Department of Cardiovascular Diseases, Division of Cardiology, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, BelgiumView further author information
,
Reinhold Kreutzco Institute of Clinical Pharmacology and Toxicology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, GermanyView further author information
&
Liffert Vogtcp Department of Internal Medicine, Section of Nephrology, Amsterdam University Medical Center, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, the NetherlandsView further author information
 show all
Article: 2368800 | Received 08 May 2024, Accepted 05 Jun 2024, Published online: 23 Jun 2024

References

  • Mancia G, Kreutz R, Brunstrom M, et al. 2023 ESH guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874–2071.
  • Kidney Disease: Improving Global Outcomes Blood Pressure Work Group. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3S):S1–S87.
  • Gourdy P, Darmon P, Dievart F, et al. Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM). Cardiovasc Diabetol. 2023;22(1):79. doi: 10.1186/s12933-023-01798-4.
  • Kidney Disease: Improving Global Outcomes CKDWG. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117–S314.
  • Halimi J-M, Sarafidis P, Azizi M, et al. Screening and management of hypertensive patients with chronic kidney disease referred to hypertension excellence centres among 27 countries. A pilot survey based on questionnaire. J Hypertens. 2024. doi: 10.1097/HJH.0000000000003756.
  • Rossignol P, Massy ZA, Azizi M, et al. The double challenge of resistant hypertension and chronic kidney disease. Lancet. 2015;386(10003):1588–1598. doi: 10.1016/S0140-6736(15)00418-3.
  • Wagner S, Metzger M, Flamant M, et al. Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - the NephroTest study. BMC Nephrol. 2017;18(1):295. doi: 10.1186/s12882-017-0710-7.
  • Bakris GL, Weir MR, Shanifar S, et al. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med. 2003;163(13):1555–1565. doi: 10.1001/archinte.163.13.1555.
  • Pohl MA, Blumenthal S, Cordonnier DJ, et al. Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. J Am Soc Nephrol. 2005;16(10):3027–3037. doi: 10.1681/ASN.2004110919.
  • Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet. 1997;349(9069):1857–1863.
  • Chen C, Zhu XY, Li D, et al. Clinical efficacy and safety of spironolactone in patients with resistant hypertension: a systematic review and meta-analysis. Medicine. 2020;99(34):e21694. doi: 10.1097/MD.0000000000021694.
  • Bakris GL, Agarwal R, Anker SD, et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med. 2020;383(23):2219–2229. doi: 10.1056/NEJMoa2025845.
  • Pitt B, Filippatos G, Agarwal R, et al. Cardiovascular events with finerenone in kidney disease and type 2 diabetes. N Engl J Med. 2021;385(24):2252–2263. doi: 10.1056/NEJMoa2110956.
  • Agarwal R, Filippatos G, Pitt B, et al. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J. 2022;43(6):474–484. doi: 10.1093/eurheartj/ehab777.
  • Sawami K, Tanaka A, Node K. Recent understandings about hypertension management in type 2 diabetes: what are the roles of SGLT2 inhibitor, GLP-1 receptor agonist, and finerenone? Hypertens Res. 2023;46(8):1892–1899. doi: 10.1038/s41440-023-01324-9.
  • Sarafidis PA, Blacklock R, Wood E, et al. Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic. Clin J Am Soc Nephrol. 2012;7(8):1234–1241. doi: 10.2215/CJN.01150112.
  • Morales J, Palmer BF. Non-steroidal mineralocorticoid antagonists and hyperkalemia monitoring in chronic kidney disease patients associated with type II diabetes: a narrative review. Postgrad Med. 2024;136(2):111–119. doi: 10.1080/00325481.2024.2316572.
  • Morales E, Cravedi P, Manrique J. Management of chronic hyperkalemia in patients with chronic kidney disease: an old problem with news options. Front Med. 2021;8:653634. doi: 10.3389/fmed.2021.653634.
  • Einhorn LM, Zhan M, Hsu VD, et al. The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med. 2009;169(12):1156–1162. doi: 10.1001/archinternmed.2009.132.
  • Epstein M, Reaven NL, Funk SE, et al. Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors. Am J Manag Care. 2015;21(11 Suppl):S212–S20.
  • Yildirim T, Arici M, Piskinpasa S, et al. Major barriers against renin-angiotensin-aldosterone system blocker use in chronic kidney disease stages 3-5 in clinical practice: a safety concern? Ren Fail. 2012;34(9):1095–1099. doi: 10.3109/0886022X.2012.717478.
  • Fu EL, Evans M, Clase CM, et al. Stopping renin-angiotensin system inhibitors in patients with advanced CKD and risk of adverse outcomes: a nationwide study. J Am Soc Nephrol. 2021;32(2):424–435. doi: 10.1681/ASN.2020050682.
  • Walther CP, Winkelmayer WC, Richardson PA, et al. Renin-angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease. Nephrol Dial Transplant. 2021;36(10):1893–1899. doi: 10.1093/ndt/gfaa300.
  • Hannedouche T, Rossignol P, Darmon P, et al. Early diagnosis of chronic kidney disease in patients with diabetes in France: multidisciplinary expert opinion, prevention value and practical recommendations. Postgrad Med. 2023;135(7):633–645. doi: 10.1080/00325481.2023.2256208.
  • An J, Kurella Tamura M, Odden MC, et al. Prevalence of apparent treatment-resistant hypertension in chronic kidney disease in two large US health care systems. Clin J Am Soc Nephrol. 2022;17(10):1457–1466. doi: 10.2215/CJN.04110422.
  • Halimi J-M, de Fréminville J-B, Gatault P, et al. Characteristics and prognosis of patients with hypertensive encephalopathy: a french nationwide cohort study. Hypertension. 2023;80(8):1716–1727. doi: 10.1161/HYPERTENSIONAHA.123.21226.
  • Halimi J-M, de Fréminville J-B, Gatault P, et al. Long-term impact of cardiorenal syndromes on major outcomes based on their chronology: a comprehensive French nationwide cohort study. Nephrol Dial Transplant. 2022;37(12):2386–2397. doi: 10.1093/ndt/gfac153.
  • Boulestreau R, Lorthioir A, Persu A, et al. Revisiting malignant hypertension: rationale and design of the ‘HAMA cohort’, on behalf of the ESH working group ‘hypertension and the kidney’. J Hypertens. 2023;41(3):453–458. doi: 10.1097/HJH.0000000000003357.
  • Sarafidis PA, Georgianos PI, Zebekakis PE. Comparative epidemiology of resistant hypertension in chronic kidney disease and the general hypertensive population. Semin Nephrol. 2014;34(5):483–491. doi: 10.1016/j.semnephrol.2014.08.001.
  • Halimi JM. [SGLT2 inhibitors: a new era for our patients]. Nephrol Ther. 2021;17(3):143–148. doi: 10.1016/j.nephro.2020.12.006.
  • Sarafidis P, Papadopoulos CE, Kamperidis V, et al. Cardiovascular protection with sodium-glucose cotransporter-2 inhibitors and mineralocorticoid receptor antagonists in chronic kidney disease: a milestone achieved. Hypertension. 2021;77(5):1442–1455. doi: 10.1161/HYPERTENSIONAHA.121.17005.
  • Sarafidis P, Ortiz A, Ferro CJ, et al. Sodium–glucose co-transporter-2 inhibitors for patients with diabetic and nondiabetic chronic kidney disease: a new era has already begun. J Hypertens. 2021;39(6):1090–1097. doi: 10.1097/HJH.0000000000002776.
  • Sarafidis P, Schmieder R, Burnier M, et al. A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) guidelines for the management of arterial hypertension. Nephrol Dial Transplant. 2024;39(6):929–943.
  • Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117–2128. doi: 10.1056/NEJMoa1504720.
  • Neal B, Perkovic V, Mahaffey KW, et al. Optimizing the analysis strategy for the CANVAS program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials. Diabetes Obes Metab. 2017;19(7):926–935. doi: 10.1111/dom.12924.
  • Herrington WG, Staplin N, Wanner C, et al. Empagliflozin in patients with chronic kidney disease. N Engl J Med. 2023;388(2):117–127. doi: 10.1056/NEJMoa2204233.
  • Rossing P, Caramori ML, Chan JCN, et al. Executive summary of the KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease: an update based on rapidly emerging new evidence. Kidney Int. 2022;102(5):990–999. doi: 10.1016/j.kint.2022.06.013.
  • Navaneethan SD, Zoungas S, Caramori ML, et al. Diabetes management in chronic kidney disease: synopsis of the KDIGO 2022 clinical practice guideline update. Ann Intern Med. 2023;176(3):381–387. doi: 10.7326/M22-2904.
  • Mottl AK, Nicholas SB. KDOQI commentary on the KDIGO 2022 update to the clinical practice guideline for diabetes management in CKD. Am J Kidney Dis. 2024;83(3):277–287. doi: 10.1053/j.ajkd.2023.09.003.
  • Weber T, Amar J, de Backer T, et al. Covid-19 associated reduction in hypertension-related diagnostic and therapeutic procedures in Excellence Centers of the European Society of Hypertension. Blood Press. 2022;31(1):71–79. doi: 10.1080/08037051.2022.2060182.
  • Burnier M, Prejbisz A, Weber T, et al. Hypertension healthcare professional beliefs and behaviour regarding patient medication adherence: a survey conducted among European Society of Hypertension Centres of Excellence. Blood Press. 2021;30(5):282–290. doi: 10.1080/08037051.2021.1963209.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.